Tags

Type your tag names separated by a space and hit enter

[Management of non-malignant results in core needle biopsy of breast lesions].
Zhonghua Yi Xue Za Zhi. 2008 Sep 09; 88(34):2387-90.ZY

Abstract

OBJECTIVE

To study the strategy of management of non-malignant results in core needle biopsy (CNB) of breast lesions.

METHODS

Consecutive 2654 breast lesions underwent CNB with 14-gauge automated needles. 1130 lesions with diagnosis of non-malignant breast lesions examined by CNB were followed up. The histological diagnosis of CNB, subsequent excision or repeat CNB, and the follow-up for cases without repeat biopsy were studied.

RESULTS

Among the 1130 non-malignant breast lesions examined by CNB, 530 underwent re-biopsy and 73 cases of carcinoma were found. 491 lesions were followed up for 1 - 38 months (median, 13.3 months) and another 4 cases of carcinoma were found during the follow-up. 109 cases were lost to follow-up. 57.9% (22/38) of the atypical ductal hyperplasia, 22.2% (4/18) of the atypical ductal cells, 27.9% (24/86) of the papillary lesions, and 90.0% (9/10) of the suspicious carcinoma diagnosed by CNB were re-diagnosed as breast cancer finally.

CONCLUSIONS

Repeat biopsy is required for the high-risk lesions diagnosed by breast CNB. Excision can be avoided on the benign lesions whose CNB diagnosis is consistent with those by physical examination and imaging.

Authors+Show Affiliations

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Breast Cancer Center, Peking University School of Oncology, Beijing Cancer Hospital, Beijing 100142, China. zhqfan@sina.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article
Research Support, Non-U.S. Gov't

Language

chi

PubMed ID

19087711

Citation

Fan, Zhao-Qing, et al. "[Management of Non-malignant Results in Core Needle Biopsy of Breast Lesions]." Zhonghua Yi Xue Za Zhi, vol. 88, no. 34, 2008, pp. 2387-90.
Fan ZQ, Ouyang T, Li JF, et al. [Management of non-malignant results in core needle biopsy of breast lesions]. Zhonghua Yi Xue Za Zhi. 2008;88(34):2387-90.
Fan, Z. Q., Ouyang, T., Li, J. F., Wang, T. F., Xie, Y. T., Fan, T., Zhang, Z., & Lin, B. Y. (2008). [Management of non-malignant results in core needle biopsy of breast lesions]. Zhonghua Yi Xue Za Zhi, 88(34), 2387-90.
Fan ZQ, et al. [Management of Non-malignant Results in Core Needle Biopsy of Breast Lesions]. Zhonghua Yi Xue Za Zhi. 2008 Sep 9;88(34):2387-90. PubMed PMID: 19087711.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Management of non-malignant results in core needle biopsy of breast lesions]. AU - Fan,Zhao-Qing, AU - Ouyang,Tao, AU - Li,Jin-Feng, AU - Wang,Tian-Feng, AU - Xie,Yun-Tao, AU - Fan,Tie, AU - Zhang,Zhe, AU - Lin,Ben-Yao, PY - 2008/12/18/entrez PY - 2008/12/18/pubmed PY - 2009/5/21/medline SP - 2387 EP - 90 JF - Zhonghua yi xue za zhi JO - Zhonghua Yi Xue Za Zhi VL - 88 IS - 34 N2 - OBJECTIVE: To study the strategy of management of non-malignant results in core needle biopsy (CNB) of breast lesions. METHODS: Consecutive 2654 breast lesions underwent CNB with 14-gauge automated needles. 1130 lesions with diagnosis of non-malignant breast lesions examined by CNB were followed up. The histological diagnosis of CNB, subsequent excision or repeat CNB, and the follow-up for cases without repeat biopsy were studied. RESULTS: Among the 1130 non-malignant breast lesions examined by CNB, 530 underwent re-biopsy and 73 cases of carcinoma were found. 491 lesions were followed up for 1 - 38 months (median, 13.3 months) and another 4 cases of carcinoma were found during the follow-up. 109 cases were lost to follow-up. 57.9% (22/38) of the atypical ductal hyperplasia, 22.2% (4/18) of the atypical ductal cells, 27.9% (24/86) of the papillary lesions, and 90.0% (9/10) of the suspicious carcinoma diagnosed by CNB were re-diagnosed as breast cancer finally. CONCLUSIONS: Repeat biopsy is required for the high-risk lesions diagnosed by breast CNB. Excision can be avoided on the benign lesions whose CNB diagnosis is consistent with those by physical examination and imaging. SN - 0376-2491 UR - https://www.unboundmedicine.com/medline/citation/19087711/[Management_of_non_malignant_results_in_core_needle_biopsy_of_breast_lesions]_ L2 - http://journal.yiigle.com/LinkIn.do?linkin_type=pubmed&issn=0376-2491&year=2008&vol=88&issue=34&fpage=2387 DB - PRIME DP - Unbound Medicine ER -